Rate-setters in Moscow lowered their forecast for consumer price inflation and opened the door to a cut in official interest as soon as 2019.
Trading on Wall Street has gotten off to a volatile start with weak German manufacturing figures sparking worries about global growth, sending traders scurrying for the relative safety of the fixed income space, although some strategists continued to see gains ahead.
Activity in the US manufacturing sector hit a 21-month low in March, according to preliminary data released on Friday.
Second hand sales of homes in the States rebounded sharply last month, bolstered by lower mortgage rates, growing incomes and improved consumer confidence.
Germany’s manufacturing output has shrunk to the lowest level for more than six and a half year, industry data showed on Friday.
Markets in Asia posted underwhelming gains on Friday, after a choppy session in which investors were still trying to make sense of a more dovish Fed in the US, along with a fresh slew of data.
Biogen shares plummeted on Thursday after the company confirmed that it will cease clinical trials for aducanumab, the experimental Alzheimer’s disease treatment it developed alongside its Nikkei 225-listed Japanese partner Eisai.
European stocks ended Thursday's session mostly lower as investors digested a more dovish than expected policy announcement from the Fed, with banks under pressure.
Perhaps the most widely-followed regional manufacturing gauge in the US rebounded sharply in March, but according to economists continued to point to an ongoing slowdown.
US stocks edged higher in early trade on Thursday as investors mulled fresh readings on manufacturing and jobs and continued to mull over a more dovish than expected policy statement from the Federal Reserve, which has prompted concerns about the US economy.
US jobless claims, one of the most closely-followed indicators of the health of the jobs market, dropped more sharply than expected over the preceding week.
Most markets in Asia were in positive territory as they closed on Thursday, as investors digested news that the US Federal Reserve was standing pat on interest rates, and likely continuing to do so for the rest of the year.
Wall Street's main stockmarket gauges were moving lower on Wednesday as investors opt to stay on the sidelines ahead of the latest policy announcement from the Federal Reserve.
US crude oil inventories shrank sharply during the preceding week as exports and refinery activity picked up.
Holland's coalition government is at risk of losing its Senate majority in provincial elections due to be held on Wednesday evening as the Eurosceptic Forum for Democracy climbs in the polls.
The chief executive of UBS has called the last three months one of the worst quarters in investment banking’s recent history.
Markets in Asia were mostly in negative territory as they closed on Wednesday, as investors struggled to make sense of the latest news from the ongoing trade tensions between the US and China.
International courier services and air freight giant FedEx reported a sharp drop in both sales and profits for its third quarter, blaming its weaker-than-expected performance on its international arm.
US stock futures pointed to a broadly flat open on Wall Street on Wednesday as investors kept their powder dry ahead of the latest policy announcement from the Federal Reserve.
US pharmaceutical group Pfizer has bought a 15% stake in Vivet Therapeutics and now has an exclusive option to buy out the rest of the privately-held French gene therapy company.